Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Frontiers in Immunology|March 7, 2019
B Cells as a Therapeutic Target in Paediatric Rheumatic DiseaseMeredyth G Ll Wilkinson, Elizabeth C Rosser
Frontiers in Immunology|February 14, 2022
The Role of Immunometabolism in the Pathogenesis of Systemic Lupus ErythematosusGeorge Anthony Robinson, Meredyth G Ll Wilkinson, Chris Wincup
Clinical and Experimental Rheumatology|February 28, 2022
Juvenile dermatomyositis. Where are we now?Liza J McCann, Polly Livermore, Meredyth G Ll Wilkinson, et al.
Nature Reviews. Rheumatology|May 15, 2023
Juvenile idiopathic inflammatory myositis: an update on pathophysiology and clinical careCharalampia Papadopoulou, Christine Chew, Meredyth G Ll Wilkinson, et al.
Pediatric Rheumatology Online Journal|September 26, 2021
JAK inhibitors: a potential treatment for JDM in the context of the role of interferon-driven pathologyMeredyth G Ll Wilkinson, Claire T Deakin, Charalampia Papadopoulou, et al.
Rheumatology (Oxford, England)|July 12, 2019
Using peripheral blood immune signatures to stratify patients with adult and juvenile inflammatory myopathiesMeredyth G Ll Wilkinson, Anna Radziszewska, Chris Wincup, et al.
Clinical and Experimental Immunology|December 25, 2024
Type I interferon and mitochondrial dysfunction are associated with dysregulated cytotoxic CD8+ T cell responses in juvenile systemic lupus erythematosusAnna Radziszewska, Hannah Peckham, Restuadi Restuadi, et al.
Annals of the Rheumatic Diseases|December 23, 2022
Role of CD14+ monocyte-derived oxidised mitochondrial DNA in the inflammatory interferon type 1 signature in juvenile dermatomyositisMeredyth G Ll Wilkinson, Dale Moulding, Thomas C R McDonnell, et al.
Annals of the Rheumatic Diseases|August 10, 2025
Spatial transcriptomic analysis of muscle biopsy from patients with treatment-naive juvenile dermatomyositis reveals mitochondrial abnormalities despite disease-related interferon-driven signatureAris E Syntakas, Melissa Kartawinata, Nia M L Evans, et al.
Frontiers in Immunology|July 11, 2018
CD19+CD24hiCD38hi B Cells Are Expanded in Juvenile Dermatomyositis and Exhibit a Pro-Inflammatory Phenotype After Activation Through Toll-Like Receptor 7 and Interferon-αChristopher J M Piper, Meredyth G Ll Wilkinson, Claire T Deakin, et al.
Pageof 2